Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.12%591.43B | 5.25%157.9B | -1.34%154.12B | 3.74%142.83B | -3.09%136.59B | 18.31%584.86B | 4.85%150.02B | 22.92%156.22B | 24.90%137.68B | 23.69%140.94B |
Cost of revenue | 1.09%552.29B | 5.19%147.3B | -1.36%144.35B | 3.35%132.88B | -2.77%127.75B | 18.56%546.34B | 4.00%140.04B | 24.23%146.34B | 25.62%128.57B | 23.92%131.39B |
Gross profit | 1.63%39.14B | 6.12%10.6B | -1.06%9.77B | 9.18%9.94B | -7.50%8.84B | 14.87%38.52B | 18.29%9.99B | 6.31%9.88B | 15.47%9.11B | 20.65%9.55B |
Operating expense | 3.15%25.85B | 3.28%6.58B | 0.67%6.49B | 5.26%6.45B | 3.52%6.33B | 6.73%25.06B | 11.03%6.37B | 7.07%6.45B | 4.08%6.12B | 4.82%6.11B |
Operating profit | -1.21%13.3B | 11.13%4.02B | -4.32%3.28B | 17.24%3.5B | -27.08%2.51B | 33.86%13.46B | 33.72%3.61B | 4.90%3.43B | 48.95%2.98B | 64.97%3.44B |
Net non-operating interest income (expenses) | -50.04%-1.76B | 3.03%-416M | -40.56%-506M | -95.89%-429M | -149.08%-406M | -77.16%-1.17B | -135.71%-429M | -126.42%-360M | -21.67%-219M | -16.43%-163M |
Non-operating interest income | 43.81%325M | 75.95%139M | -21.28%37M | 87.72%107M | -2.33%42M | 77.95%226M | 132.35%79M | 42.42%47M | 119.23%57M | 26.47%43M |
Non-operating interest expense | 49.03%2.08B | 9.25%555M | 33.42%543M | 94.20%536M | 117.48%448M | 77.28%1.4B | 135.19%508M | 111.98%407M | 33.98%276M | 18.39%206M |
Net investment income | 46.38%303M | 200.96%626M | -13.84%-995M | -129.63%-72M | 18.10%744M | -78.44%207M | -25.18%208M | -438.76%-874M | 4.29%243M | 229.84%630M |
Gain(Loss) on financial instruments designated as cash flow hedges | 848.39%294M | -101.56%-905M | 58.41%1.82B | 106.61%23M | -100.94%-641M | 111.27%31M | -23.69%-449M | 2,830.95%1.15B | -11,500.00%-348M | -339.85%-319M |
Gain(Loss) on derecognition of available-for-sale financial assets | 29.50%619M | 0 | -111.86%-21M | 517M | 6.96%123M | 690.12%478M | 386.15%186M | 177M | 0 | 784.62%115M |
Income from associates and other participating interests | -83.58%123M | -63.87%56M | -75.71%17M | 264.29%23M | -94.98%27M | 36.68%749M | 96.20%155M | -30.69%70M | -107.87%-14M | 183.16%538M |
Special income (charges) | 169.28%1.31B | 2,017.86%1.19B | 120M | 0 | 0 | 506.25%485M | -90.49%56M | 0 | 18M | 411M |
Less:Other special charges | 93.16%-29M | ---- | ---- | ---- | ---- | 41.84%-424M | --5M | --0 | ---18M | ---411M |
Less:Write off | -1,993.44%-1.28B | -1,796.72%-1.16B | ---- | ---- | ---- | -107.33%-61M | -143.57%-61M | ---- | ---- | ---- |
Other non-operating income (expenses) | 9.73%-603M | -67.66%-280M | 45.45%-66M | 35.47%-171M | 25.22%-86M | -336.60%-668M | -447.92%-167M | -61.33%-121M | -5,400.00%-265M | 12.21%-115M |
Income before tax | 0.08%13.58B | 34.92%4.28B | 5.25%3.65B | 41.24%3.38B | -49.98%2.27B | 29.58%13.57B | 2.85%3.17B | 30.40%3.47B | 0.21%2.4B | 93.93%4.54B |
Income tax | 10.22%4.49B | 65.63%1.7B | -3.53%847M | -1.55%1.01B | -18.57%925M | 43.14%4.07B | -25.79%1.03B | 0.11%878M | 239.93%1.03B | 305.71%1.14B |
Net income | -4.27%9.09B | 20.18%2.58B | 8.23%2.8B | 73.57%2.37B | -60.50%1.34B | 24.54%9.5B | 26.24%2.15B | 45.23%2.59B | -34.55%1.37B | 65.13%3.4B |
Net income continuous operations | -4.26%9.1B | 20.22%2.58B | 8.23%2.8B | 73.50%2.37B | -60.47%1.34B | 24.52%9.5B | 26.16%2.15B | 45.31%2.59B | -34.58%1.37B | 65.13%3.4B |
Noncontrolling interests | -105.59%-17M | 91.43%-3M | -333.33%-14M | -55.26%17M | -105.76%-17M | -38.21%304M | -120.11%-35M | -80.00%6M | 46.15%38M | 12.60%295M |
Net income attributable to the company | -0.92%9.11B | 18.33%2.58B | 9.06%2.82B | 77.24%2.35B | -56.17%1.36B | 28.87%9.2B | 42.89%2.18B | 47.46%2.58B | -35.65%1.33B | 72.88%3.11B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -0.92%9.11B | 18.33%2.58B | 9.06%2.82B | 77.24%2.35B | -56.17%1.36B | 28.87%9.2B | 42.89%2.18B | 47.46%2.58B | -35.65%1.33B | 72.88%3.11B |
Gross dividend payment | ||||||||||
Basic earnings per share | -0.70%1.04K | 18.32%293.38 | 9.11%319.98 | 77.38%267.27 | -55.88%154.75 | 29.38%1.04K | 43.85%247.95 | 48.27%293.27 | -35.30%150.68 | 72.90%350.75 |
Diluted earnings per share | -0.70%1.04K | 18.32%293.38 | 9.74%319.98 | 78.36%267.27 | -55.88%154.75 | 29.38%1.04K | 43.85%247.95 | 47.46%291.5682 | -35.65%149.8493 | 72.90%350.75 |
Dividend per share | 0.00%315 | 15.15%190 | 0 | -16.67%125 | 0 | 28.57%315 | 3.13%165 | 0 | 76.47%150 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |